Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.51%
#2 Fake World Assets Fake World Assets +18.28%
#3 Status Status +17.90%
#4 GoPlus Security GoPlus Security +11.51%
#5 Ontology Gas Ontology Gas +10.01%
#6 Bedrock Bedrock +7.70%
#7 DMT-NAT DMT-NAT +7.61%
#8 Cap Cap +6.73%
#9 Provenance Blockchain Provenance Blockchain +6.73%
#10 Janction Janction +5.45%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
सेटिंग्स
भाषा
हिन्दी
मुद्रा
USD
थीम
Renalytix Plc Renalytix Plc

Renalytix Plc

RNLX
शेयरों में रैंक #33998
Renalytix Plc, established in New York in 2018 and known as Renalytix AI plc... Renalytix Plc, established in New York in 2018 and known as Renalytix AI plc until its name change in June 2021, focuses on creating artificial intelligence-driven in vitro diagnostic tools for kidney ailments. Its primary product, KidneyIntelX, is an advanced diagnostic system that utilizes an AI-powered algorithm. This algorithm integrates multiple data sources, including scientifically validated blood markers, genetic predispositions, and individual patient information from electronic health records, to produce a distinct risk score for kidney disease. The company's technology is applied in various areas: identifying and predicting the course of kidney disease, informing clinical treatment, selecting patients for pharmaceutical trials, and discovering new therapeutic targets. Renalytix has formed several strategic collaborations, such as licensing agreements with Mount Sinai Health System for AI-assisted kidney disease diagnosis, with Joslin Diabetes Center, Inc. for developing biomarker-based kidney disease prediction products, and with Kantaro Biosciences LLC for laboratory tests to detect SARS-CoV-2 antibodies. Furthermore, it has partnered with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to introduce an innovative clinical care model aimed at improving kidney health outcomes and preventing disease advancement and failure in vulnerable populations.
शेयर मूल्य
$0.1502
अंतिम समन्वयन: 2024-11-04
मार्केट कैप
$6.43M
बदलाव (1 दिन)
-5.45%
बदलाव (1 वर्ष)
0.00%
देश
US
व्यापार Renalytix Plc (RNLX)

श्रेणी

Healthcare
Renalytix Plc (RNLX) के लिए बकाया शेयरों की संख्या
September 2024 की स्थिति में बकाया शेयरों की संख्या: 52.85M
Renalytix Plc की नवीनतम वित्तीय रिपोर्ट और शेयर मूल्य के अनुसार, कंपनी के वर्तमान बकाया शेयरों की संख्या 52.85M है। June 2023 के अंत में कंपनी के पास 41.11M बकाया शेयर थे। बकाया शेयरों की संख्या आमतौर पर शेयर स्प्लिट्स और शेयर बायबैक से प्रभावित होती है।
Renalytix Plc (RNLX) के लिए 2018 से 2026 तक बकाया शेयरों का इतिहास
प्रत्येक वर्ष के अंत में बकाया शेयर
वर्ष बकाया शेयर परिवर्तन
2026 (TTM) 52.85M -2.29%
2024 54.09M 31.59%
2023 41.11M 20.93%
2022 33.99M -4.07%
2021 35.43M 22.38%
2020 28.95M 36.05%
2019 21.28M 1.82%
2018 20.90M 0.00%
समान कंपनियों या प्रतिस्पर्धियों के लिए बकाया शेयर
कंपनी बकाया शेयर अंतर देश
GE HealthCare Technologies Inc. GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc.
GEHC.US
 453.00M 757.16%
US
Pro Medicus Limited Pro Medicus Limited
Pro Medicus Limited
PME.AX
 104.48M 97.70%
AU
BrightSpring Health Services, Inc. Common Stock BrightSpring Health Services, Inc. Common Stock
BrightSpring Health Services, Inc. Common Stock
BTSG.US
 205.38M 288.62%
US
Tempus AI, Inc. Tempus AI, Inc.
Tempus AI, Inc.
TEM.US
 179.92M 240.44%
US
Signify Health, Inc. Signify Health, Inc.
Signify Health, Inc.
SGFY.US
 - -
US